Elsevier Vice Chairman Chi to lead Science & Technology Division

Herman van Campenhout to join a Dutch company as CEO

Amsterdam, 4 December 2009 - Elsevier announced today the appointment of Youngsuk “Y.S.” Chi, the company’s Vice Chairman, to serve as Chief Executive Officer of Elsevier’s Science & Technology (S&T) Division. The appointment follows the decision by division CEO Herman van Campenhout to accept a new position as CEO of a publicly listed Dutch company early next year. “We wish Herman every success in his new job and thank him for his contributions,” said Reed Elsevier CEO Erik Engstrom.

“Elsevier Science & Technology has a clear strategy and a strong management team. We are very fortunate that our Vice Chairman can step in immediately as CEO of S&T to help that team continue to build on its successful track record,” said Engstrom. Chi will continue to report directly to Engstrom.

Chi, 48, has been Vice Chairman of Elsevier for almost five years. During that time he has led the company’s Global Academic & Customer Relations efforts and has been deeply engaged in S&T’s business. He has more than 15 years of management experience in publishing and technology.

Chi will also continue to serve on the Reed Elsevier Management Committee and to oversee government affairs for Reed Elsevier.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact:
Anna Hogrebe
+31 20 485 3269